Federal research dollars banned from dog and cat testing

What it does

This bill prohibits the Department of Health and Human Services and its agencies (NIH, CDC, FDA, and others) from funding biomedical research that uses live dogs or cats. It covers all aspects of such research—acquiring, breeding, housing, testing on, and euthanizing the animals—and applies to direct federal funding and indirect support through overhead costs. The bill includes narrow exceptions for veterinary care, observational studies, and rehoming of previously used animals, plus emergency waivers for public health or national security crises. Recipients must certify compliance, maintain records, and face funding withholding or recovery if they violate the ban.

Why we flagged it

The bill's core mechanism is a direct prohibition on federal funding for a specific category of biomedical research (dog and cat testing), paired with enforcement, transparency, and whistleblower protections. It is a spending restriction tied to ethical/welfare values, not a tax provision, subsidy, or commemorative measure.

What the text implies

• The bill's 180-day implementation delay allows current federally funded dog/cat research to continue through the transition period, potentially creating a rush to complete studies before the ban takes effect.
• The emergency waiver mechanism (Section 5) permits the Secretary to override the ban for up to 180 days if a public health emergency, national emergency, or national security threat is declared—a broad discretionary power that could be invoked during pandemics or biodefense scenarios.
• Institutions receiving federal research funding must now maintain 6-year records and submit annual certifications of compliance, creating administrative overhead and audit exposure for universities and research hospitals.
• The bill does not restrict private (non-federal) funding of dog/cat biomedical research, so such work may continue at institutions using only private dollars, creating a potential two-tier research environment.
• Whistleblower protections (Section 10) may incentivize reporting of violations but could also create internal friction at research institutions if employees report colleagues for suspected noncompliance.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill restricts government spending on a practice many citizens find ethically objectionable (testing on companion animals) and redirects federal research dollars away from that use. Citizens gain transparency and alignment of federal funding with public values regarding animal welfare, with narrow emergency exceptions preserved for genuine public health threats.

Who stands to gain

• animal sanctuaries and rescue organizations (increased demand for rehoming and care of retired resea
• alternative research method developers (in vitro, computational, and animal-model alternatives may s
• compliance and audit service providers (institutions will need legal and compliance support)

Named in the bill

Department of Health and Human Services, National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Advanced Research Projects Agency for Health, Biomedical Advanced Research and Development Authority, Agency for Healthcare Research and Quality, Office of Inspector General, Comptroller General, Committee on Energy and Commerce, Committee on Health, Education, Labor, and Pensions, Animal Welfare Act

Where it stands

15 cosponsors: 10 Democrats, 5 Republicans.

• Sep 21, 2026 — Introduced · Congress.gov: “Introduced in House”
• Sep 21, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.